Literature DB >> 3877617

Sudden death after catheter-induced atrioventricular junctional ablation.

S Bharati, M M Scheinmann, F Morady, D S Hess, M Lev.   

Abstract

Atrioventricular (AV) junctional ablation was performed in a 59-year-old woman with recurrent atrial fibrillation refractory to treatment with digoxin, beta-blockers, verapamil, quinidine, procainamide, and amiodarone. She received two shocks of 500 J which produced complete AV block. After six weeks, both 24-hour ECG recordings and an exercise tolerance test showed infrequent premature ventricular complexes, 3 degrees AV block, and paced ventricular rhythm with 100 percent capture. She suddenly collapsed and was found to be in ventricular fibrillation and could not be resuscitated. Serial sections of the conduction system showed marked fatty infiltration of the approaches to the AV node with almost complete separation from the node. A partially fibrosed atrioHisian connection was also present. Fibroelastosis with chronic inflammatory changes was present in the AV node, bundle of His, and right and left bundle branches. In addition, marked inflammatory changes with fibrosis were present in the atrial septum, in the summit of the ventricular septum, with degenerative changes in the tricuspid and aortic valves. The sequelae of these findings outside the conduction system in other patients remains to be determined.

Entities:  

Mesh:

Year:  1985        PMID: 3877617     DOI: 10.1378/chest.88.6.883

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

Review 1.  Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome.

Authors:  Jason C Rubenstein; James A Roth
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

2.  Electrode catheter ablation of resistant ventricular tachycardia in arrhythmogenic right ventricular dysplasia: experience of 15 patients with a mean follow-up of 45 months.

Authors:  G Fontaine; R Frank; I Rougier; J Tonet; Y Gallais; G Farenq; G Lascault; M Lilamand; F Fontaliran; G Chomette
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.